Assessment of cardiac involvements in rheumatic diseas using a cardiac magnetic resonance approach

Assessment of cardiac involvements in rheumatic diseas using a cardiac magnetic resonance approach - Assessment of cardiac involvements in reumatic disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022140

Enrollment

128

Registered

2016-04-29

Start date

2015-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)All rheumatic disease patients were over twenty years old and met the American College of Rheumatology criteria. 2)Cardiac symptoms were absent in all subjects.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had prior self-reported, physician-diagnosed cardiovascular events or procedures, such as myocardial infarction, angioplasty, and CHF. Additional exclusions were diabetes (HbA1c>6.1), hypertension ((systolic blood pressure (BP) >140 mm Hg and/or diastolic BP>90 mm Hg), and dyslipidemia (LDL cholesterol levels >140 mg/dL, an HDL cholesterol level<40 mg/dL, or a triglyceride level>150 mg/dL).History of bronchoconstriction, contraindication to MRI, hypersensivity to gadolinium were absent in all subjects

Design outcomes

Primary

Measure	Time frame
We explored the association of cardic MRI abnomalities with disease activity, patients characterstics, and biomaker in rheumatic disease patients	—

Secondary

Measure	Time frame
To detect the influence of treatment agents in cardiac involvements	—

Countries

Japan

Contacts

Public ContactAkiko Hirama

Nihon University School of Medicine Division of Hematology and Rheumatology

hirama.akiko@nihon-u.ac.jp0339728111

Outcome results